Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Enrolling By InvitationNCT06737354
What this trial is testing

Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).

Who this might be right for
nAMD
InnoVec Biotherapeutics Inc. 18
Testing effectiveness (Phase 2)UnknownNCT03594461
What this trial is testing

Intense Treatment Regimen With Intravitreal Aflibercept Injection

Who this might be right for
Neovascular Age-Related Macular Degeneration
Vitreous -Retina- Macula Consultants of New York 30
Early research (Phase 1)Study completedNCT04744662
What this trial is testing

ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
ONL Therapeutics 28
Large-scale testing (Phase 3)Looking for participantsNCT07461441
What this trial is testing

Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)Age Related Macular Degeneration
Yeungnam University College of Medicine 50
Not applicableLooking for participantsNCT07135570
What this trial is testing

"My Eyes, My Light": Amar Chokh, Amar Alo

Who this might be right for
GlaucomaDiabetic Retinopathy (DR)Hypertensive Retinopathy+6 more
Data Yakka, Inc. 20,000
Early research (Phase 1)UnknownNCT03305029
What this trial is testing

The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD

Who this might be right for
Dry Age Related Macular Degeneration
CHA University 3
Large-scale testing (Phase 3)Study completedNCT01327222
What this trial is testing

Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
IRCCS San Raffaele 20
Large-scale testing (Phase 3)Ended earlyNCT00619229
What this trial is testing

Alprostadil in Maculopathy Study (AIMS)

Who this might be right for
Macular Degeneration
UCB Pharma 37
Testing effectiveness (Phase 2)Study completedNCT04270669
What this trial is testing

Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
RemeGen Co., Ltd. 37
Early research (Phase 1)Study completedNCT03387566
What this trial is testing

Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Huabo Biopharm Co., Ltd. 21
Not applicableStudy completedNCT00001738
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) in Uveitis

Who this might be right for
Macular Edema, CystoidUveitis
National Eye Institute (NEI) 60
Not applicableStudy completedNCT01840683
What this trial is testing

HELP Therapy for Dry AMD

Who this might be right for
Non-exudative (Dry) Age-related Macular Degeneration (AMD)
B.Braun Avitum AG 22
Early research (Phase 1)Study completedNCT01271270
What this trial is testing

Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 5
Not applicableActive Not RecruitingNCT06686641
What this trial is testing

Incidence of Macular Edema in a Uveitis Population

Who this might be right for
Macular EdemaNon-infectious Uveitis
Aalborg University Hospital 1,550
Testing effectiveness (Phase 2)Study completedNCT02357342
What this trial is testing

Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD

Who this might be right for
Age-Related Macular Degeneration
Maturi, Raj K., M.D., P.C. 40
Not applicableStudy completedNCT04499703
What this trial is testing

Evaluation of the Retinal Health Monitoring System Thickness Module

Who this might be right for
Macular EdemaMacular Degeneration
Kubota Vision Inc. 60
Post-approval studies (Phase 4)Study completedNCT01846273
What this trial is testing

Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)

Who this might be right for
Age-related Macular DegenerationPolypoidal Choroidal Vasculopathy
Novartis Pharmaceuticals 321
Large-scale testing (Phase 3)Study completedNCT01661946
What this trial is testing

Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

Who this might be right for
Diabetic Macular Edema
Queen's University 10
Not applicableStudy completedNCT01411696
What this trial is testing

Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 289
Not applicableStudy completedNCT07749027
What this trial is testing

Comparison Between Low-Dose and High-Dose Nepafenac Sodium

Who this might be right for
Cataract
Muhammad Aamir Latif 176
Next Page